Pfizer Lilly: Different Bets on Pharma M&A Explained
Eli Lilly posts a blockbuster start to 2026 as Pfizer works to rebuild after the COVID era, highlighting pfizer lilly...
A zero-spend month concentrates spending to essentials, directing more money toward debt. Plan, track, and celebrate smaller, steady wins.
16,055 articlesEli Lilly posts a blockbuster start to 2026 as Pfizer works to rebuild after the COVID era, highlighting pfizer lilly...
Chevron reports stronger-than-expected Q1 2026 results and advancing Hess synergy-driven production, but investors de...
The Senate confirmed Kevin Warsh to lead the Federal Reserve, setting the stage for policy shifts as inflation stays ...
A Valvoline executive explains how the company backs young workers through mentorship, fair pay, and career paths ami...
Opendoor's CEO recently bought 100,000 shares, signaling confidence to shareholders. This article breaks down what t...
ExxonMobil and Chevron post contrasting Q1 results as oil prices rebound, highlighting divergent paths to dividends. ...
A Kentucky GOP primary produced a win for a Trump-backed challenger, marking a new chapter in Trump’s hold on the par...
Parsons Corp faces a tough mix: a record backlog rising margins boost profitability, yet an upcoming policy and contr...
A former Google engineer turned $7.2 AI CEO says the hiring surge is real, but the toughest filter is drive and work ...
Klarna and Sezzle stand out in the evolving fintech scene, but they offer very different risk/reward profiles. This g...
A sudden setback from a key launch partner has jolted AST SpaceMobile investors. This guide explains the causes, pote...
A top psychologist says the decade-long drop in U.S. reading scores isn’t caused by immigration, but by pervasive dev...